Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fibrogen Inc CS (NQ: FGEN )

0.3851 -0.0149 (-3.73%)
Streaming Delayed Price Updated: 1:38 PM EDT, Sep 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Fibrogen Inc CS

< Previous 1 2 3 4 5 6 7 Next >
What 3 FibroGen Analysts Are Expecting From Thursday's Roxadustat Adcom Verdict
FibroGen, Inc. (NASDAQ:FGEN) has a key catalyst Thursday w... 
Via Benzinga
Ahead Of AdComm AstraZeneca, FibroGen's Roxadustat Hit With Safety, Efficacy Questions
Ahead of Thursday's meeting of the FDA's Cardiovascular and Renal Drugs Advisory Committee, the agency is raising fresh doubts on the safety of AstraZeneca Plc's... 
Via Benzinga
Exposures Product Safety
The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix
Biopharma stocks closed the holiday-shortened week lower amid a lack of any significant news flow. On the drug approval front, Provention Bio, Inc. (NASDAQ: PRVB) faced a setback... 
Via Benzinga
Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates
June was a month of plenty and also turned out to be a fruitful one from the perspective of Food and Drug Administration approvals. Regulatory reviews mostly produced positive... 
Via Benzinga
Earnings Scheduled For May 10, 2021
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report... 
Via Benzinga
Mizuho Downgrades FibroGen to Neutral on 'Higher Risk And Uncertainty'
Mizuho analyst Difei Yang downgraded FibroGen to Neutral from Buy with a price target of $29, down from $72. 
Via Talk Markets
14 Biotech Stocks To Watch Over The Next 6 Months
Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks. A case in point was the strong upside in Biogen Inc.'s (NASDAQ:... 
Via Benzinga
The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,... 
Via Benzinga
Exposures COVID-19
Why FibroGen's Stock is Down During Today's Session
FibroGen's Stock Price And Volume Action FibroGen's (NASDAQ:FGEN 
Via Benzinga
FibroGen In-Licenses Three HiFiBiO Programs For Cancer, Autoimmune Settings
FibroGen Inc (NASDAQ: FGEN) and HiFiBiO Therapeutics have entered into a licensing agreement for three programs in the immuno-oncology and autoimmune space.... 
Via Benzinga
FibroGen Inc (FGEN) Q1 2021 Earnings Call Transcript
FGEN earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
3 Biotech Stocks Ripe for Spring Portfolio Cleaning
All down 45% or more from their 52-week highs, should you consider cutting your losses? 
Via The Motley Fool
The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
Contrary to the strength in the broader market, biotech stocks ended the week ending April 9 lower. The weakness partly reflected a preference for risky bets at the expense of... 
Via Benzinga
Exposures Product Safety
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
Exposures COVID-19 Product Safety
Stocks That Hit 52-Week Lows On Friday
On Friday morning, 13 companies achieved new lows for the year. Intriguing Points: The largest company by market cap to set a new 52-week low was Cia Paranaense De... 
Via Benzinga
The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 8) Aclaris Therapeutics, Inc... 
Via Benzinga
Stock Market Rally Gains Steam As Apple, Microsoft, Google, Facebook Lead Tech Revival: Weekly Review
The Nasdaq fully joined the market rally, as Microsoft, Google and Facebook broke out while Apple and other growth stocks rebounded. The S&P 500 hit ahigh. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Stocks That Hit 52-Week Lows On Thursday
On Thursday morning, 6 companies achieved new lows for the year. Areas of Significance: Viatris (NASDAQ:VTRS) was the largest, in terms of market cap, to set a new... 
Via Benzinga
The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 7) Aclaris Therapeutics, Inc... 
Via Benzinga
Exposures Product Safety
36 Biggest Movers From Yesterday
Gainers UTime Limited (NASDAQ: UTME) shares jumped 110.7% to close at $82.17 on Wednesday. UTime shares jumped 875% on Tuesday after the company priced its IPO at $4 per share.... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Mid-Afternoon Market Update: Dow Falls 25 Points; Homology Medicines Shares Slide
Toward the end of trading Wednesday, the Dow traded down 0.08% to 33,404.98 while the NASDAQ rose 0.02% to 13,701.64. The S&P also rose, gaining 0.09% to 4,077.69. The... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Odonate Therapeutics (NASDAQ:ODT) stock moved upwards by 17.63% to $4.07 during Wednesday's regular session. Trading volume for this security as of 12:32 EST... 
Via Benzinga
Mid-Day Market Update: Crude Oil Down Over 1%; FibroGen Shares Plummet
Midway through trading Wednesday, the Dow traded up 0.02% to 33,437.41 while the NASDAQ rose 0.23% to 13,729.29. The S&P also rose, gaining 0.16% to 4,080.61. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
28 Stocks Moving In Wednesday's Mid-Day Session
Gainers UTime Limited (NASDAQ: UTME) jumped 97.4% to $76.99. UTime shares jumped 875% on Tuesday after the company priced its IPO at $4 per share. XL Fleet Corp. (NASDAQ: XL)... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Why FibroGen Stock Is Crashing Today
The company disclosed a bombshell related to its safety results for lead candidate roxadustat. 
Via The Motley Fool
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's morning session, 5 stocks hit new 52-week lows. Interesting Facts: Vertex (NASDAQ:VERX) was the largest company by market cap to set a new 52... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2021
Upgrades According to Janney Capital, the prior rating for Texas Capital Bancshares Inc (NASDAQ:TCBI) was changed from Neutral to Buy. Texas Capital Bancshares earned $1.... 
Via Benzinga
Mid-Morning Market Update: Markets Mostly Higher; RPM Earnings Beat Views
Following the market opening Wednesday, the Dow traded up 0.16% to 33,483.20 while the NASDAQ fell 0.05% to 13,692.06. The S&P also rose, gaining 0.12% to 4,078.93. The U.S.... 
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
10 Biggest Price Target Changes For Wednesday
Keybanc raised Applied Materials, Inc. (NASDAQ: AMAT) price target from $144 to $151. Applied Materials shares rose 0.1% to $139.65 in pre-market trading. Needham boosted SMART... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Titan Medical (NASDAQ:TMDI) shares rose 26.81% to $2.27 during Wednesday's pre-market session. The market value of their outstanding shares is at $248.6... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.